The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice (Q42707432)
Jump to navigation
Jump to search
scientific article published on 13 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice |
scientific article published on 13 January 2014 |
Statements
1 reference
The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice (English)
1 reference
Masamichi Mori
1 reference
Yoko Ueno
1 reference
Satoshi Konagai
1 reference
Hiroshi Fushiki
1 reference
Itsuro Shimada
1 reference
Yutaka Kondoh
1 reference
Rika Saito
1 reference
Kenichi Mori
1 reference
Nobuaki Shindou
1 reference
Takatoshi Soga
1 reference
Hideki Sakagami
1 reference
Takashi Furutani
1 reference
Hitoshi Doihara
1 reference
Masafumi Kudoh
1 reference
Sadao Kuromitsu
1 reference
13 January 2014
1 reference
1 reference
Identifiers
1 reference